Black Rock Inc. Neuro Metrix, Inc. Transaction History

Black Rock Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	BUY	$1.36 - $22.72 $3,453 - $57,686	2,539 Added 6.67%	40,589 $60,000
Q2 2022 Aug 12, 2022	SELL	$2.81 - $5.5 $5,620 - $11,000	-2,000 Reduced 4.99%	38,050 $140,000
Q1 2022 May 12, 2022	BUY	$3.42 - $6.37 $6,840 - $12,740	2,000 Added 5.26%	40,050 $166,000
Q4 2021 Feb 10, 2022	BUY	$5.02 - $9.82 $40,672 - $79,561	8,102 Added 27.05%	38,050 $191,000
Q3 2021 Nov 09, 2021	BUY	$3.23 - $24.73 $92,668 - $709,503	28,690 Added 2280.6%	29,948 $304,000
Q2 2021 Aug 11, 2021	BUY	$2.72 - $3.8 $3,421 - $4,780	1,258 New	1,258 $4,000

320

Ticker NURO
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 7,757,230
Market Cap $31.3M
Description
NeuroMetrix, Inc., a healthcare company, engages in designing, building, and marketing medical devices that stimulate and analyze nerve response for diagnostic and therapeutic purposes in the United States, Europe, Japan, China, the Middle East, and Mexico. Its primary marketed products include DPNCheck, a nerve conduction test that is used to e...

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

Stay updated on Black Rock Inc. with notifications on news.